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Lyme disease is a multisystemic disorder caused by Borrelia burgdorferi infection. Upon infection, some B. burgdorferi genes are
upregulated, including members of the microbial surface components recognizing adhesive matrix molecule (MSCRAMM) pro-
tein family, which facilitate B. burgdorferi adherence to extracellular matrix components of the host. Comparative genome anal-
ysis has revealed a new family of B. burgdorferi proteins containing the vonWillebrand factor A (vWFA) domain. In the present
study, we characterized the expression andmembrane association of the vWFA domain-containing protein BB0172 by using in
vitro transcription/translation systems in the presence of microsomal membranes and with detergent phase separation assays.
Our results showed evidence of BB0172 localization in the outer membrane, the orientation of the vWFA domain to the extracel-
lular environment, and its function as a metal ion-dependent integrin-binding protein. This is the first report of a borrelial adhe-
sin with a metal ion-dependent adhesion site (MIDAS) motif that is similar to those observed in eukaryotic integrins and has a
similar function.
Lyme disease is amultisystemic disorder that leads to arthritis in60% of cases, carditis in 10% of untreated adults, and other
neurological symptoms. The causative agent of Lyme disease is the
spirochetal pathogen Borrelia burgdorferi, which is transmitted to
humans through the bite of an infected Ixodes sp. tick (1). There is
currently very little information available on the tissue-specific
host-pathogen interactions that lead to pathological manifesta-
tions of B. burgdorferi infection. This pathogen’s ability to colo-
nize mammals is dependent on its capacity to rapidly alter gene
expression in response to highly disparate environmental signals
following transmission from infected ticks (2). The open reading
frames that are upregulated upon infection include members of
the microbial surface components recognizing adhesive matrix
molecules (MSCRAMM) protein family, and they facilitate the
adherence of B. burgdorferi to extracellularmatrix (ECM) compo-
nents of the host (3).
Comparative genome analysis has also identified a family of
von Willebrand factor A (vWFA) domain-containing proteins in
B. burgdorferi, including BB0172, BB0173, BB0175, and BB0325
(4–6). The vWFA domains present in ECM proteins and on eu-
karyotic cells are involved in cell adhesion and protein-protein
interactions; they play key roles in the adhesion of platelets to
areas of vascular damage by binding to glycoproteins on the plate-
let surface, to exposed ECM components (5, 7, 8), and to metal-
loproteases (ADAMTS 13) (7–12). Therefore, the vWFA domain-
containing borrelial proteinsmight be involved in the adhesion of
B. burgdorferi to eukaryotic cells, ECMcomponents, and activated
platelets, and they may thus play a role in the virulence mecha-
nisms of B. burgdorferi. In humans, absence of vWF results in
severe bleeding disorders due to the removal of blood clotting
factor VIII from the circulation (12–15). vWF-binding proteins
(vWFbp) have been identified in several bacterial species, such as
Helicobacter pylori and Staphylococcus aureus (16–19), and these
secreted or surface-exposed proteins are involved in the binding of
these pathogens to ECM components, platelets, and endothelial
cells, thus playing an important role in pathogen colonization and
dissemination in the mammalian host. In silico sequence analysis
has shown that B. burgdorferi vWFA domain-containing proteins
have a sequence domain (DXSXS) that is very similar to the metal
ion-dependent adhesion site (MIDAS) found in integrins (20, 21).
These proteins also show similarity to the Plasmodium spp. extra-
cellular adhesion molecule TRAP and the LFA-1 integrin (Fig. 1)
(6, 22).
The Lyme disease agent binds to a variety of ECM components
and integrins, which are metal ion-dependent heterodimeric re-
ceptors that mediate cell-to-cell and cell-to-ECM interactions
(23). The present study used a well-established in vitro model to
investigate the localization and function of the vWFA domain-
containing BB0172 protein of B. burgdorferi and to determine its
function in adherence to different tissues during infection. Our
findings established the topology of the BB0172 protein in biolog-
ical membranes and its adherence to different ECM components
and integrins, emphasizing the complexity of host-pathogen in-
teractions in Lyme disease.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Borrelia burgdorferi B31 iso-
late A3 (24) was used throughout this study. Tomimic the temperature
and pH conditions during the transition of this bacterium from the
unfed to the fed tick, the strain was grown in BSK-II medium pH 7.6
complemented with 6% inactivated normal rabbit serum at room tem-
perature (RT) until reaching a density of 107 cells/ml. Then an aliquot
of this culture was transferred to BSK-II medium (pH 6.8) and incu-
bated at 37°C with 1% CO2 until reaching a density of 5# 10
7 cells/ml
(25). Escherichia coli OneShot Top10 cells (Invitrogen, CA) were used
for all cloning steps, and Rosetta-gami(DE3)pLysS cells (Novagen,
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Madison, WI) were used for BB0172 recombinant protein expression.
All E. coli strains were grown in LB (Difco) broth with the appropriate
antibiotics.
RNA and genomic DNA purification for detecting bb0172 tran-
scripts by PCR. RNA was extracted as previously described (25, 26).
Briefly, B. burgdorferi cultures were grown to a density of 2# 107 to 3#
107 spirochetes/ml under the shifting conditions outlined above. RNA
was extracted by resuspending the bacterial pellets with 0.2 ml RNA-Bee
(Tel-Test, Inc., Friendswood, TX) for every 106 cells. Following extraction
with chloroform, RNA was precipitated with isopropanol, washed with
75% ethanol, air dried, and resuspended in RNase-free water. To remove
contaminating DNA, the RNA was treated twice with DNase I at 37°C for
45 min. Then, the total RNA was quantified spectrophotometrically and
reverse transcribed to cDNA by using TaqMan reverse transcription re-
agents (Applied Biosystems, Foster City, CA). From B. burgdorferi cul-
tures growing under tick-feeding conditions (pH 6.8, 37°C) or regular
growing conditions (pH 7.6, 32°C), genomic DNA was obtained by gen-
eral phenol-chloroform extraction.
RNA, cDNA, and genomic DNA (positive control) samples from
each growing condition were used to detect when bb0172 was ex-
pressed. A 500-bp fragment of bb0172 was amplified using primers
BB0172cDNA-F (B. burgdorferi nucleotides 174705 to 174728) and
BB0172cDNA-R (B. burgdorferi nucleotides 174225 to 174249) (Table
1). Primers specific to the flaB, ospC, and p66 genes were also included
as controls for the temperature and pH shift (Table 1) (27, 28). PCR
products were separated on 0.8% agarose gels and imaged using the
Bio-Rad Gel Doc XR system.
Computer-assisted analysis of BB0172 transmembrane (TM) re-
gions.Membrane-spanning regions in the BB0172 sequence were predicted
byusing six of themost commonlyusedpredictionmethods available online:
DAS-TMfilter (29; http://mendel.imp.univie.ac.at/sat/DAS/DAS.html), $G
Prediction (30; http://dgpred.cbr.su.se/), MEMSAT3 (31; http://bioinf.cs.ucl
.ac.uk/psipred/submit), OCTOPUS (32; http://octopus.cbr.su.se/index
.php), SOSUI (33; http://bp.nuap.nagoya-u.ac.jp/sosui/sosui_submit.html),
and TMHMM (34; http://www.cbs.dtu.dk/services/TMHMM/). The poten-
tial presence of a putative signal sequence was also investigated using the
FIG 1 In silico analysis of BB0172. (A) Schematic representation of BB0172. TM1 and TM2, transmembrane domains 1 (amino acids 17 to 35) and 2 (amino
acids 264 to 281), respectively. The vWFA domain includes amino acids 51 to 256. The recombinant BB0172 protein (BB0172T) amino acid sequence spans
residues 38 to 291. The anti-BB0172pep antibody (Ab) was generated against a 30-mer peptide, from amino acids 150 to 180. The MIDAS motif is located at
residues 57 to 61. (B) Hydrophobic amino acid sequences (HRs) were cloned to study their insertion into membranes. HR1, amino acids 16 to 38, HR2, amino
acids 263 to 284. (C) ClustalW (v1.83) alignment of BB0172 ofB. burgdorferiB31 (in bold) andZS7 strains to its homologues inBorrelia garinii (NTL01BG0170),
Borrelia afzelii (NTL07BA0169), and the relapsing fever species Borrelia hermsii (NT03BH0168) and Borrelia tunicate (NT06BT0168), as well as to the human
adhesins LFA-1 andCD11b and thePlasmodium falciparummembrane protein TRAP. Bold text with gray shadowing indicates theMIDASdomain (DXSXS) and
the aspartic acid (D) necessary to complete themetal binding (20, 21). The threonine (T) that is highlighted in gray and underlined is also involved in theMIDAS
motif function; it is present in a different location in the bacterial species compared to eukaryotic counterparts. MacVector version 12.6 (MacVector, Inc.) was
used for sequence analyses and production of schematics.
BB0172, a New Metal-Dependent Adhesin
August 2013 Volume 195 Number 15 jb.asm.org 3321
SignalP 4.0 server (35; http://www.cbs.dtu.dk/services/SignalP/). All user-ad-
justable parameters were left at their default values.
Cloning of transmembrane domain regions. To study the insertion
of BB0172 hydrophobic regions into membranes, the segments to be
tested (Fig. 1A and B) were engineered into the luminal P2 domain of the
integral membrane protein Lep from E. coli (leader peptidase), where it
was flanked by two N-glycosylation sites that were used as reporters (see
Fig. 5, top). To further clone these regions, the two BB0172 putative TM
domains were PCR amplified from total genomic DNA obtained from the
B31A3 Borrelia strain by using the primers described in Table 1. PCR
product size was verified on 2% agarose gels, and then amplicons were
cleaned using the Wizard SV gel and PCR cleanup system (Promega,
Madison,WI), following themanufacturer’s recommendations. The PCR
products were then double digested using SpeI/KpnI enzymes (NEB, Ip-
swich, MA) and cloned into pGEM-Lep as previously described (36–38).
Ligation reaction mixtures were precipitated overnight and electropo-
rated into TOP10 cells. Positive clones were selected on ampicillin plates
(100 %g/ml) and verified by sequencing (Eton Biosciences, San Diego,
CA). Clones showing the hydrophobic TMs in frame with Lep were used
for the in vitro transcription-translation experiments.
In vitro transcription-translation. In vitro translation of in vitro-
transcribed mRNA was performed in the presence of reticulocyte lysate,
[35S]Met-Cys, and dog pancreas microsomes, as described previously
(39). Lep constructs with hydrophobic region (HR)-tested segments from
the BB0172 sequence (residues 16 to 38 and 263 to 284) were transcribed
and translated as previously reported (36). After translation, membranes
were collected by ultracentrifugation and analyzed by sodium-dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the gels
were visualized on a Fuji FLA3000 PhosphorImager with ImageGauge
software.
The proteinase K protection assay was performed as previously de-
scribed (40). Briefly, the translation mixture was supplemented with 1 %l
CaCl2 (50 mM) and 1%l proteinase K (4 mg/ml) and then digested for 40
min on ice. The reaction was stopped by adding 1 mM phenylmethylsul-
fonyl fluoride (PMSF), followed by SDS-PAGE analysis. This process is
shown schematically in Fig. 5, below.
Expression and purification of BB0172T. For this experiment, a trun-
cated BB0172 (BB0172T) protein was purified to avoid insertion of the
protein into E. colimembranes and to ensure purification of BB0172 as a
soluble protein. Total genomic DNA obtained from the B31A3 strain
(Table 2) was used as a template to PCR amplify bb0172 from nucleotides
150 to 873 (amino acids 50 to 290), using the primers listed in Table 1. The
ampliconswere cloned into the pCR2.1-TOPOvector (Invitrogen), trans-
formed into E. coli TOP 10 cells, and subjected to blue/white colony
screening in the presence of ampicillin (100 mg/ml) and kanamycin (50
mg/ml). The insert was digested with NdeI/XhoI and ligated into the
pET23a expression vector. The ligated products were electrotransformed
into E. coli TOP10 cells and screened for the presence of the insert by
restriction enzymedigestion. The junctions of plasmids containing inserts
of the expected sizes were sequenced and used to transform the E. coli
expression host. Recombinant BB0172 (rBB0172) with a C-terminal
6#His tag was overexpressed by inducing the E. coli strain containing
pET23a-bb0172T with 1 mM isopropyl-"-D-thiogalactopyranoside for 3
h. The bacterial pellets were disrupted by using a French press and dena-
turing lysis buffer (8Murea, 20mM imidazole; pH 7.4). The supernatants
were collected, clarified by centrifugation, and subjected to affinity puri-
fication with aHis60 Ni Superflow resin (Clontech,Mountain View, CA),
following themanufacturer’s instructions. The bound 6#His-tagged pro-
teins were eluted as 0.5-ml fractions with elution buffer (8 M urea, 300
mM imidazole; pH 7.4) and then analyzed by SDS–12.5% PAGE. Select
fractions with the largest concentrations of eluted proteins were further
purified using dialysis against 50 mM sodium phosphate and 300 mM
NaCl (pH 7.4; Slide-A Lyze G2 dialysis cassette; Thermo Scientific). After
dialysis, Amicon centrifugal filters (Millipore) were used to concentrate
the proteins. A 27.5-kDa protein was purified to homogeneity (data not
TABLE 1 Oligonucleotide primers used in this study
Primer pair RSa Sequence (5=¡3=)b Application
BB0172cDNA-F GCTTGATTTTTTTAATTTTATCC Amplification of bb0172 500-bp fragment
from B. burgdorferi cDNABB0172cDNA-R CGGGATTACTCCCGCCAATCCCAA
FlaBcDNA-F AACACACCAGCATCACTTTCAGG Amplification of flab 234-bp fragment
from B. burgdorferi cDNAFlaBcDNA-R GAGAATTAACTCCGCCTTGAGAAGG
P66cDNA-F CAAAAAAGAAACACCCTCAGATCC Amplification of p66 683-bp fragment
from B. burgdorferi cDNAP66cDNA-R CCTGTTTTTAAATAAATTTTTGTAGCATC
OspCcDNA-F TATTAATGACTTTATTTTTATTTATATCT Amplification of ospC 593-bp fragment
from B. burgdorferi cDNAOspCcDNA-R TTGATTTTAATTAAGGTTTTTTTGG
BB0172TF NdeI ACGCCATATGTGGGGGCAAAGAGCTGTTGAGGA Amplification of bb0172 for cloning into
pCR2.1 and pET23a for protein
expression and purification
BB0172TR XhoI ACGCCTCGAGCTAAAAAGTTTCGTCCCA
BB0172TM1-F SpeI ACGCACTAGTGGAGGACCAGGAGTTCTAATGTCAATGTTT Amplification of the first bb0172
hydrophobic region in frame with Lep
sequence
BB0172TM1-R KpnI ACGCGGTACCCCTCCTGGTCCCCAAGAAATATCCAAAAT
BB0172TM2-F SpeI ACGCACTAGTGGAGGACCAGGAAGATATAAAATTTTTTTG Amplification of the second bb0172
hydrophobic region in frame with Lep
sequence
BB0172TM2-R KpnI ACGCGGTACCCCTCCTGGTCCTATCATCCTGACAAACAA
BB0172-T ACAGATGGCGATGATTGGGGGGAA Sequencing
SP6 ATTTAGGTGACACTATAG Sequencing
BB0172 SDMMIDAS-1F GAGAATTTCTTTTATTTTTGCTATTTCTCGTAGCATG Site-directed mutagenesis of the first
amino acid of the MIDAS motif,
DXSXS¡AXSXS
BB0172 SDMMIDAS-1R CATGCTACGAGAAATAGCAAAAATAAAAGAAATTCTC
BB0172 SDMMIDAS-2F GAGAATTTCTTTTATTTTTGATATTGCTCGTAGCATGTTAAG Site-directed mutagenesis of the second
amino acid of the MIDAS motif,
DXSXS¡DXAXS
BB0172 SDMMIDAS-2R CTTAACATGCTACGAGCAATATCAAAAATAAAAGAAATTCTC
BB0172 SDMMIDAS-3F GAGAATTTCTTTTATTTTTGATATTTCTCGTGCTATGTTAAGTGTAGATG Site-directed mutagenesis of the third
amino acid of the MIDAS motif,
DXSXS¡DXSXA
BB0172 SDMMIDAS-3R CATCTACACTTAACATAGCACGAGAAATATCAAAAATAAAAGAAATTCTC
BB0172 SDMMIDAS-3X-F GAGAATTTCTTTTATTTTTGCTATTGCTCGTGCTATGTTAAGTGTAGATG Site-directed mutagenesis of the three
amino acids of the MIDAS motif,
DXSXS¡AXAXA
BB0172 SDMMIDAS-3X-R CATCTACACTTAACATAGCACGAGCAATAGCAAAAATAAAAGAAATTCT
a Restriction sites (RS), when present, are indicated by bold text in the sequence.
b Site-directed mutations are underlined in the sequence.
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shown), quantified in a bicinchoninic acid (BCA; Thermo Scientific, Inc.)
assay, and stored at&80°C until further use.
Site-directed mutagenesis of DXSXS metal-binding domain.
BB0172 contains a MIDAS motif (Fig. 1C) comprising amino acids 57 to
61 (DXSXS). To determine which amino acids are essential for maintain-
ing this protein’s function, we performed site-directed mutagenesis to
change the motif-relevant amino acids to alanine, creating the mutants
D57A, S59A, and S61A and the triple mutant (21). For this process, we
used the QuikChange II XL site-directed mutagenesis kit (Agilent Tech-
nologies), following the manufacturer’s recommendations. Primers (Ta-
ble 1) were designed as recommended by the manufacturer and using
their primer design tool for site-directed mutagenesis. Positive colonies
were screened by sequencing using the universal T7 promoter and termi-
nator primers (Eton Biosciences, Ltd., San Diego, CA). Mutant MIDAS
motif clones were stored at &80°C for further use. For their expression
and purification, 2 %l of purified plasmid for each mutation was electro-
porated into Rosetta-gami E. coli strains (Novartis). Further binding as-
says were performed with all isolated mutants, as described below.
Generation of specific BB0172 antibodies. To generate antibodies
specific to the extracellular domain of BB0172, we design a 30-mer-long
peptide corresponding to amino acids 150 to 180 (Fig. 1A) with the se-
quence YNFLVILTDG DDWGENNYYR FSKFVNNLKL conjugated to
KLH (Peptide 2.0, Chantilly, VA). The synthetic peptide was dissolved in
10% dimethyl sulfoxide until reaching homogeneity and administered to
three BALB/cmice at a dose of 50%g/mouse in conjugationwithTiterMax
Gold (Sigma-Aldrich, St. Louis,MO) on days 0, 14, and 21. At 28 days, the
mice were euthanized and exsanguinated. Serum was collected and used
in the following immunoblot and binding assays; this specific antiserum is
henceforth referred to as anti-BB0172pep. Specific serum to the whole
BB0172 protein was obtained following the same immunization protocol
and using 50%g of rBB0172T permouse, butwe detected noBB0172 in the
B. burgdorferiwhole-cell lysates or from purified rBB0172T. Therefore, we
used the anti-BB0172pep developed in this study.
Triton X-114 partitioning of B. burgdorferi outer membrane pro-
teins. To evaluate the localization of BB0172 in B. burgdorferi, we sepa-
rated the outer membrane proteins (OMPs) from the protoplasmic cyl-
inders (PCs) by Triton X-114 partitioning as previously described (40–
43). Briefly, B. burgdorferiwas grown at RT and pH 7.6 and then shifted to
37°C, pH 6.8 and grown to a density of 5# 107 spirochetes/ml. Cells were
washed in phosphate-buffered saline (PBS), resuspended in PBS contain-
ing 1% Triton X-114, and incubated overnight at 4°C with gentle rocking
to ensure separation of the outer membrane proteins without disruption
of the protoplasmic cylinders. After the overnight partitioning, PCs were
pelleted by centrifugation at 15,000 # g for 15 min at 4°C. Supernatants
containingOMPswere incubated at 37°C for 15min in the presence of 2%
Triton X-114. The OMP-containing organic phase was separated by cen-
trifugation at 2,000# g for 10min at RT and thenwashed three timeswith
PBS. Finally the OMPs were precipitated out of the organic phase by
adding 10# ice-cold acetone at&20°C for 2 h, followed by centrifugation
at 15,000# g for 30min at 4°C. PCs, the aqueous phase, and the detergent
phase containing the OMPs from different growing conditions were sep-
arated in SDS–12% PAGE gels and silver stained (Silver Staining Plus;
Bio-Rad Laboratories, Inc., Hercules, CA), following the manufacturer’s
recommendations, or transferred to polyvinylidene difluoride (PVDF)
membranes to determine the BB0172 localization by immunoblot assay as
described below. OMPs OspC and P66, the periplasmic protein superox-
ide dismutase A (SodA), and the cytosolic proteins carbon storage regu-
lator A (CsrA) and theBorrelia oxidative stress regulator (BosR)were used
as controls.
SDS-PAGE gels and immunoblot analysis. Borrelia burgdorferi
whole-cell lysates (prepared from cultures grown at RT and pH 7.6, then
shifted to pH6.8 and 37°C)were treatedwith proteinaseK (20%g/ml) and
separated by SDS–12.5% PAGE. The separated proteins were either visu-
alized by Coomassie brilliant blue staining or transferred onto a PVDF
membrane (Hybond-P; GE Healthcare, Piscataway, NJ) and subjected to
immunoblot analysis. The PVDF membranes were blocked overnight at
4°C in Tris-buffered saline containing 0.2% Tween 20 (TBS-T) and 10%
skim milk. After blocking, membranes were probed with mouse anti-
BB0172pep. Polyclonalmouse anti-P66 and anti-OspC (25) sera were used
as controls for proteinase K activity on outer membrane proteins and
controls for the fractioning of outer membrane proteins in the Triton-
X114 partitioning assay. Polyclonal mouse anti-SodA and rabbit anti-
BosR sera were used as controls of cytoplasm-located proteins (44). The
blots were developed following incubation with appropriate dilutions of
horseradish peroxidase (HRP)-conjugated secondary antibodies and us-
ing enhanced chemiluminescenceWestern blotting reagents (GE Health-
care, Piscataway, NJ) as previously described (25, 26, 44, 45).
Binding assays. To understand the possible capability of BB0172 to
bind to ECMs, we purified a truncated BB0172 protein lacking the N
terminus and the first TM segment (BB0172T) (Fig. 1), andwe analyzed its
binding to collagen type I, collagen type IV, laminin, and humanfibronec-
tin (BD BioCoat, Bedford, MA). All incubations were performed using
HBS buffer (HEPES-buffered saline) containing 0.25 mM Ca2', 1 mM
Mn2', 1 mMMg2', and 1% bovine serum albumin (BSA) (46, 47). After
blocking plates with 3% BSA in HBS containing 1% Tween 20 (HBS-T),
we added 500 ng/well of rBB0172T or rBBK32 (positive binding control)
TABLE 2 Bacterial strains and plasmids used in this study
Strain or plasmid Genotype Source
Borrelia burgdorferi B31A3 cp9&, wild type Rocky Mountain
Labs (1)
E. coli strains
OneShot Top10 Cloning host; F&mcrA $(mrr-hsdRMS-mcrBC) (80lacZ$M15 $lacX74 recA1 araD139 $(ara leu)7697
galU galK rpsL(Strr) endA1 nupG
Invitrogen
Rosetta-gami(DE3)pLysS Expression host; $(ara leu)7697 $lacX74 $phoA PvuII phoR araD139 ahpC galE galK rpsL DE3 F=
[lac' lacIq pro] gor522::Tn10 trxB pLysS RARE2 (Camr Kanr Strr Tetr)
Novagen
Plasmids
pGEM-Lep Cloning host, containing E. coli Lep, leader peptidase (Ampr) 82
pLE102 pGEM-1(bb0172TM1-Lep) This study
pLE103 pGEM-1(bb0172TM2-Lep) This study
pLE136 pET23a(bb017250–290) This study
pECW1 pET23a (bb017250–290-AXSXS) This study
pECW2 pET23a (bb017250–290-DXAXS) This study
pECW3 pET23a (bb017250–290-DXSXA) This study
pECW3X pET23a (bb017250–290-AXAXA) This study
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to the plates in quadruplicate wells and incubated them at RT for 1 h
(47–49). The plates were washed three times with HBS-T to remove un-
bound BB0172T protein. Then, plates were incubated with a 1:1,000 dilu-
tion of mouse-anti-rBB0172pep or 1:2,000 dilution of the mouse anti-
rBBK32 antibody for 1 h at RT, followed by a 1-hour incubation with a
1:5,000 dilution of anti-mouse HRP-conjugated antibody (GE Health-
care, Piscataway, NJ). Plates were washed and incubated with o-phenyl-
diamine dihydrochloride (OPD) tablets (Thermo Scientific), and the ab-
sorbency at 450 nm was measured by using a FLUOstar Omega plate
reader (BMG LabTech, Cary, NC). A blank control (BK) was included in
quadruplicate in all plates.
To evaluate the binding of rBB0172T to a wider range of ECMs and
integrins, and to prevent any interference of the anti-rBB0172 antibody
with binding capabilities to the substrates, 96-well flat-bottom plates
(Nunc) were coated with 500 ng/well of each of the recombinant proteins:
rBB0172, rBBK32, and rP66. All incubations used HBS buffer containing
0.25 mM Ca2', 1 mM Mn2', and 1 mM Mg2' (46, 47). After coating
overnight at 4°C in carbonate buffer, pH 9.2, plates were washed and
blocked using HBS-T with 3% BSA buffer for 2 h at RT. Blocked plates
were washed with HBS-T and incubated for 1 h at RT with 500 ng/well of
each of the ECM components (human plasma fibronectin, human tissue
fibronectin, aggrecan, decorin, vitronectin, elastin, and fibrinogen; Sig-
ma-Aldrich, Co., LLC) and integrins (!1"1, !3"1, !V"3, !V"5, and !5"1;
EMD Millipore Corporation) (46, 47). After washing, plates were incu-
bated for 1 h at RT with each respective anti-ECM component or anti-
integrin antibody. The plates were washed again, and a secondary HRP-
conjugated antibody was applied for 1 h at RT, followed by development
with OPD tablets (Thermo Scientific) and measurement of the A450 as
described above. Wells without ECM components or integrins were used
as blanks. The effects of the mutations in the MIDAS motif of BB0172
were also evaluated by analyzing their binding to !3"1 integrin following
the same protocol described above.
Statistical analysis. Two-way analysis of variance was used to deter-
mine significant differences in the binding of BB0172T to the different
integrins and extracellular matrix components, along with the Sidakmul-
tiple comparison test with a 95% confidence interval. Analyses were per-
formed using Prism 6.0d (GraphPad Software, Inc.).
RESULTS
B. burgdorferi expression and localization of BB0172 protein.
We found that the bb0172 gene was not expressed when B. burg-
dorferiwas grown at RT and pH 7.6, while an mRNA product was
detected when cultures were shifted from RT/pH 7.6 to either
37°C/pH 6.8 or 32°C/pH 7.6 (Fig. 2, compare lanes 1 and 3 in A to
lanes 1 and 4 in B). Evaluation of flaB, p66, and ospC gene expres-
sion at themRNA level showed the presence of flaB and p66 under
both the RT/pH 7.6 and the temperature-pH (T/pH)-shifting
conditions, while ospC was expressed only under T/pH-shifting
conditions (Fig. 2A). These results suggested that bb0172 gene
expression is selectively triggered by a change in temperature.
Therefore, in subsequent studies, we adopted the temperature and
pH shift strategy to induce BB0172 expression on borrelial cells
and to detect the protein.
We next evaluated the cellular localization of the BB0172 pro-
tein in B. burgdorferi based on proteinase K sensitivity and Triton
X-114 partitioning of OMPs, followed by immunoblot analysis
(Fig. 3). TheBB0172 proteinwas only present in cultures thatwere
shifted to 37°C/pH 6.8, not in RT cultures (Fig. 3B, lane 1). This
result correlates with the RNA data, supporting the hypothesis
that this protein is expressed during the change from RT condi-
tions to warmer conditions (32°C to 37°C). Furthermore, the pro-
teinwas not observed after proteinaseK treatment, suggesting that
the vWFA domain of this protein (against which the antibodies
were generated) is accessible from outside the cell.
We also evaluated the presence of BB0172 in the outer mem-
brane fraction ofB. burgdorferi by using TritonX-114 partitioning
of OMPs after shifting the cultures from RT/pH 7.6 to 37°C/pH
6.8. BB0172 was only detected in the OMP fraction of the shifted
B. burgdorferi cultures, not in the PC or OMP fractions extracted
from cultures grown at RT/pH 7.6 (Fig. 4B). In addition, when B.
burgdorferi was grown at 37°C/pH 6.8, the borrelial outer mem-
brane lipoprotein OspC was detected at larger amounts in the
OMP fraction than in the PC fraction. Very small amounts of
OspCwere detected in the OMP fraction isolated from cells grow-
FIG 2 BB0172 expression upon temperature shift. B. burgdorferi B31A3 strain
was grown at RT/pH 7.6 and shifted to 37°C/pH 6.8 (T/pH shift) or to
32°C/pH 7.6 (T shift). The purified mRNA was reverse transcribed to cDNA,
and PCRwas performed to detect bb0172, flaB, p66, and ospC. Water was used
as a negative control (-). (A) RNA samples from all purifications were checked
for DNA contamination and applied in lanes 2 and 4. Genomic DNA was
included as a positive control in lane 5. cDNA results are shown in lanes 1 and
3. (B) cDNA samples of cultures growing after T/pH shift or T shift are repre-
sented in lanes 1 and 4, RNA is in lanes 2 and 5, and genomic DNA is in lanes
3 and 6. The DNA ladder is shown on the left side of each panel, with the sizes
indicated in base pairs.
FIG 3 BB0172 localizes on theB. burgdorferi surface.B. burgdorferiB31A3was
cultured at RT/pH 7.6 (lane 1), shifted to 37°C/pH 6.8 (lane 2), and shifted to
37°C/pH 6.8 and treated with proteinase K (lane 3). Whole-cell lysates of all
treatments were separated on a 12% SDS-PAGE gel and stained with Coomas-
sie blue (A) or transferred to PVDF membranes and probed with mouse anti-
BB0172pep followed by anti-mouse HRP-conjugated antibody (B). OspC
(outer membrane lipoprotein), SodA (intracellular), and P66 (outer mem-
brane integral protein) were used as controls for the proteinase K treatment.
T/pH shift denotes the shift from RT/pH 7.6 to 37°C/pH 6.8.
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ing at RT/pH 7.6, and it was only detectable after overexposing the
immunoblot (data not shown). Moreover, SodA was only de-
tected in the Borrelia aqueous phase, regardless of the growing
conditions used, while BosR was only detected in the PC fraction
from cells growing at 37°C/pH 7.6. Altogether, these results con-
firmed the presence of the BB0172 protein in the outermembrane
of B. burgdorferi, with its vWFA domain oriented toward the ex-
tracellular milieu.
BB0172 is anchored to biological membranes through two
transmembrane segments.The BB0172 amino acid sequencewas
parsed to test the performance of several commonly used algorithms
for predicting TM regions of integral membrane proteins. We sub-
mitted theBB0172sequence to themost currentonlineversionsof six
widely used prediction methods: DAS-TMfilter (29), $G Predictor
(30), MEMSAT3 (31), OCTOPUS (32), SOSUI (33), and TMHMM
(34). The predicted outcomes significantly coincided across the dif-
ferent methods used, with all algorithms predicting the presence of
two TM domains at similar positions in the protein sequence (Table
3). It has been established that the reliability of a given prediction is
very highwhenmany differentmethods agree (40). Additionally, the
SignalP 4.0 (35) results predicted that it is unlikely that BB0172 con-
tains a signal sequence.
The membrane insertion of the two BB0172 hydrophobic re-
gions was investigated by using an in vitro experimental system
that accurately reports the integration of TM helices into micro-
somal membranes (Fig. 5, top) (37, 50). The translation of the
chimeric constructs harboring the predicted BB0172 TM regions
as HR-tested sequences mainly resulted in single glycosylated
forms (Fig. 5, lanes 4 to 9), suggesting membrane integration of
these two regions. Lanes 1 to 3 in Fig. 5 show the control construct
(38, 40, 51) with a previously tested computer-designed translo-
cated (nonintegrated) sequence. Proteinase K treatment of these
samples rendered complete loss of detectable fragments in the case
of the BB0172 tested sequences, while a clear protected band was
observed in the translocated control construct (Fig. 5, compare
lane 3 to lanes 6 and 9), confirming membrane insertion of the
BB0172 hydrophobic regions. Although these in vitro experiments
are not entirely representative of in vivo conditions, the results
strongly suggest that the translocon machinery can recognize the
assayed regions, ultimately ensuring their proper integration into
the intended target membrane.
Binding of BB0172 to human ECM components and integ-
rins. After characterizing the orientation in the membrane of the
BB0172 vWFA domain, the recombinant BB0172 protein was
used to perform a number of binding assays to different human
ECM components and integrins. Recombinant expression of full-
length BB0172 protein in Escherichia coli cells was not detected on
Coomassie-stained gels or Western blots (data not shown). Since
it was previously reported that the first TM segment can prevent
translation of membrane proteins in E. coli cells (52), we then
expressed a truncated version of the BB0172 protein lacking the N
terminus and the first TM segment (BB0172T) (Fig. 1). This strat-
egy enabled expression and purification of the truncated BB0172
as a recombinant protein in sufficient concentrations for further
characterization. The first set of binding experiments showed that
FIG 4 B. burgdorferiBB0172 anchors to the outermembrane. TheB. burgdorferiB31A3 strain was cultured at RT/pH 7.6 and shifted to 37°C/pH 6.8, and the PCs
and OMPs were separated by Triton X-114 partitioning. PC and OPM fractions from all treatments were separated on 12% SDS-PAGE gels and stained with
Silver Staining Plus (Bio-Rad) (A) or transferred to PVDF membranes and probed with mouse anti-BB0172pep followed by anti-mouse HRP-conjugated
antibody (B). Serum specific for OspC (outer membrane lipoprotein), SodA (periplasmic), BosR (cytoplasmic), and CsrA (cytoplasmic) were used as a controls.
T/pH shift denotes the shift fromRT/pH 7.6 to 37°C/pH 6.8.MW,molecular weightmarker; lane 1, PCs from cultures at RT/pH 7.6; lane 2, OMPs from cultures
at RT/pH 7.6; lane 3, PCs from cultures at 37°C/pH 6.8; lane 4, OMPs from cultures at 37°C/pH 6.8; lane a, aqueous phase from cultures at RT/pH 7.6; lane b,
aqueous phase from cultures at 37°C/pH 6.8.
TABLE 3 In silico analysis of the BB0172 amino acid sequence
Algorithm
Membrane
protein?
Resulting no. of TM segments (starting
amino acids/ending amino acids)
DAS-TMfilter Yes 2 (17/35 and 264/281)
$G Prediction Yes 2 (16/38 and 263/284)
MEMSAT3 Yes 2 (21/39 and 264/283)
OCTOPUS Yes 2 (17/38 and 263/283)
SOSUI Yes 4 (16/38, 177/198, 219/241, and 258/280)a
TMHMM Yes 2 (20/39 and 266/284)
a Bold numbers denote “primary” helices.
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the BB0172 proteinwas slightly bound to humanplasmafibronec-
tin in the presence of the metals Ca2', Mn2', and Mg2'; binding
to other ECM components was not observed (Fig. 6A). The bind-
ing of the BB0172 protein to human plasma fibronectin was very
weak and significantly lower than that observed for BBK32, an
extensively characterized plasma fibronectin-binding protein of
B. burgdorferi (48, 53–55).We next evaluated the binding capabil-
ity of the BB0172 protein to integrins. The BB0172 protein signif-
icantly bound to !3"1 integrin in the presence of divalent cations,
while P66 (a "3 integrin-binding protein from B. burgdorferi)
showed very low binding (Fig. 6B). This result was consistently
observed, suggesting that the BB0172 protein could be a !3"1
integrin-binding protein.
Ligand binding to integrins is usually dependent upon divalent
cations. The presence of aMIDASmotif in the BB0172 amino acid
sequence (Fig. 1C) suggests that this region may accomplish this
function by adopting a specific fold. To investigate whether this
region of BB0172 is functionally equivalent to a MIDAS domain,
we performed an alanine-scanning analysis by replacing critical
residues of the MIDAS motif (DXSXS) (Table 2) with alanine
through site-directed mutagenesis. Each single-point mutant
strain (AXSXS, DXAXS, and DXSXA) plus a triple mutant strain
harboring all three replacements (AXAXA) was used in a !3"1
integrin-binding assay. The results showed that all three individ-
ualmutations significantly reduced the binding of BB0172 to!3"1
integrin compared to the wild-type sequence (Fig. 6C), suggesting
that all three amino acid residues are important for the coordina-
tion of the metal required to maintain the function of the BB0172
protein. As expected, the triple mutation induced the highest re-
duction of binding, indicating that these amino acids play a critical
role inmaintaining the coordination ofmetals in the BB0172 pro-
tein.
DISCUSSION
vWFA domain-containing proteins are found in a broad array of
systems, from integrins in mammalian organisms to bacteria (5,
13, 56–58). To be functional, these proteins must exist on the cell
surface to interact with their receptors. The chromosome of Bor-
relia burgdorferi encodes a series of vWFA domain-containing
proteins (BB0172, BB0173, BB0175, and BB0325). Of all these
hypothetical proteins, in silico analysis only predicts those en-
coded by the bb0172 and bb0173 genes to be membrane proteins.
The main objectives of the present work were to determine the
BB0172 protein expression pattern, to demonstrate its membrane
association, and to characterize its binding to potential host com-
ponents. Furthermore, we evaluated the cellular localization of the
BB0172 vWFA domain by using proteinase K treatment and Tri-
ton X-114 partitioning, together with immunoblot analyses. Alto-
gether, the results showed that BB0172 is a helical membrane pro-
tein with two TM segments expanding from amino acids 16 to 38
and 263 to 284, suggesting a specific membrane disposition (Fig.
7). Immunoblot analysis with proteinase K-treated whole cells
consistently revealed that the vWFA domain of BB0172 was not
visible due to its degradation during treatment, indicating that the
vWFA domain was exposed to the outer cell surface. Triton X-114
partitioning experiments also demonstrated the localization of
BB0172 in the outer membrane of B. burgdorferi.
This is the first study demonstrating that a vWFA domain-
containing borrelial protein is anchored to the cell surface
through two TM helices. We could not obtain the full-length pro-
tein by in vitro translation techniques, probably due to differences
in the codon usage between B. burgdorferi and the rabbit system
utilized in these experiments. For instance, the codons for Arg
(AGA), Gln (CAA), Ile (AUU), Leu (UUA) Pro (CCU), Ser
(UCU), and Thr (ACU) that are preferentially used by B. burgdor-
feri are poorly used in rabbit (Oryctolagus cuniculus). In addition,
previous experiments conducted in our laboratory showed that
some borrelial proteins are only recombinantly expressed inE. coli
strains (Rosetta strain from Novagen) that are engineered to rec-
ognize rare codons for Leu and Ile (data not shown). Due to these
limitations, here we evaluated short polypeptide regions by using
in vitro translocation/insertion of putative TM domains in the
presence of canine pancreatic microsomes and rabbit reticulo-
cytes. While the hydrophobic regions tested here came from pro-
karyotic proteins, the high degree of sequence conservation in the
translocon components between prokaryotes and eukaryotes (59)
suggests that general conclusions can be drawn based on studies
using themicrosomal assay system and that the present results are
relevant to the study of the BB0172 surface-exposed regions of B.
FIG 5 Hydrophobic regions of the BB0172 insert into microsomal mem-
branes. (Top) Schematic representation of the Lep construct used to report
insertion into the endoplasmic reticulum (ER) membrane of BB0172 hydro-
phobic regions. The TM segment under investigation (HR-tested) was in-
serted into the P2 domain of Lep, flanked by two artificial glycosylation accep-
tor sites (G1 and G2). Recognition of the tested sequence as a TM domain by
the transloconmachinery results in the location of only G1 in the luminal side
of the ER membrane, preventing G2 glycosylation (left). The Lep chimera is
doubly glycosylated when the sequence being tested is translocated into the
lumen of themicrosomes (right). (Bottom) In vitro translation of different Lep
constructs containing BB0172 HR1 (residues 16 to 38; lanes 4 to 6) and HR2
(residues 263 to 284, lanes 7 to 9) sequences in the presence of membranes. A
control construct was used to verify sequence translocation (lanes 1 to 3).
Constructs were transcribed and translated in the presence or absence of rough
microsomal membranes (RM) and proteinase K (PK), as indicated. Bands of
nonglycosylated protein are indicated by a white dot; singly and doubly glyco-
sylated proteins are indicated by one and two black dots, respectively. The
arrowhead identifies protected a double-glycosylated P2 domain after PK
treatment.
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burgdorferi. This contention is further supported by previous ob-
servations of prokaryotic sequences based on measurements ob-
tained using this system (60). Based on our present results, this
strategy appears to be a valuable tool for studying complex mem-
brane proteins from prokaryotic organisms that are difficult to
culture in vitro but that have a sequenced genome. Further mod-
ifications of the current system utilizing a synthetic bb0172 gene
recoded with amore appropriate codon combination are in prog-
ress.
In our study, both bb0172RNA and protein were only detected
when the pathogenic B. burgdorferi B31A3 strain was shifted from
RT/pH 7.6 to 37°C/pH 6.8 or 32°C/pH 7.6. Additionally, bb0172
expression was inhibited when cells were adapted to any of the
studied temperature/pH combinations. These results suggest that
BB0172 is only present under the conditions found during the
temperature shift that is part of the transition of B. burgdorferi
from the unfed tick to the fed tick, indicating that BB0172 might
be of great importance during themigration of this pathogen from
the tick to the mammalian host. It should be noted that a recent
proteomic analysis of B. burgdorferi in response to culture condi-
tion changes detected two BB0172-derived peptides at RT/pH 7.6
but not at 34°C/pH 6.6 (61). This discrepancy with the present
data could have arisen from the differences in culture shifting
conditions between studies and from the low total number of
spectral counts found with the proteomic approach, which indi-
cates a very low abundance of BB0172 under all the conditions
studied. Taking all these observations together, we hypothesize
FIG 6 BB0172 is an integrin-binding protein. (A) Purified BB0172T was incubated with different ECM components: aggrecan, collagen I and IV, decorin, elastin,
laminin, fibrinogen, human plasma fibronectin, human tissue fibronectin, and vitronectin. Recombinant BBK32was used as a borrelial positive-control protein for the
binding to humanplasma fibronectin. (B) The binding of BB0172 to different integrins by usingHBS buffer containingCa2',Mg2', andMn2'. Recombinant P66was
used as a positive control for the binding to human integrins. BB0172 boundmore strongly to!3"1 integrin comparedwith the P66 binding. (C) Purified recombinant
BB0172 proteins containing mutations in the MIDASmotif (AXSXS, DXAX, DXSXA, and AXAXA) were incubated with !3"1 integrin. BB0172T corresponds to the
wild-type sequence. Eachmutation of theMIDASmotif altered efficacy of the binding of BB0172 to!3"1 integrin. *, P) 0.05; **, P) 0.01; ***, P) 0.001 (compared
with the control protein). All binding assays entailed four replicates for each protein in each ECM component or integrin.
FIG 7 Schematic representation of B. burgdorferi BB0172 topology. We pro-
pose that BB0172 is anchored to the borrelial outer membrane through two
TM segments located at theN terminus andC terminus of the protein and that
the vWFA domain will be exposed to the exterior of the cell. TheMIDASmotif
is also present in the external segment of this protein, actively participating in
the adhesion of BB0172 to !3"1 integrin.
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that BB0172 plays an important role as an adhesin during the first
hours postinfection. Therefore, we performed a number of bind-
ing assays to ECM components as well as to several commercially
available integrins. Our findings suggested that the BB0172 pro-
tein is a metal-dependent adhesin to the human !3"1 integrin.
Integrins are heterodimeric receptors that mediate cell-to-cell
and cell-to-ECM interactions (23, 62). Pathogenic B. burgdorferi
can target integrins and ECM components to local sites of damage
in host cells to promote bacterial dissemination (23, 63). For in-
stance, the outer membrane protein P66 interacts with integrin
!IIb"3 on the surface of activated platelets, as well as with integrin
!v"3 on endothelial cells (47, 64, 65). Similarly, B. burgdorferi
infection induces the expression of selected integrins in the C3H/
HeNmouse model, which can influence the severity of Lyme dis-
ease-derived carditis and arthritis (66, 67). Moreover, different B.
burgdorferi proteins can bind to specific ECM components; for
example, the BBK32 protein interacts with fibronectin (48, 53–
55), and decorin-binding proteins A and B (DbpA and DbpB)
interact with decorin and chondroitin (68–71). However, analysis
of borrelial mutants deficient in BBK32 or DbpA/B did not show
complete abrogation of the binding to extracellular products, sug-
gesting that this binding might be mediated by unknown func-
tionally and structurally related determinants (49).
Behera and collaborators (72) previously described BBB07, an
integrin !3"1-binding protein of B. burgdorferi. They showed that
the RGD-dependent binding of the BBB07 protein to integrins
specifically stimulated the generation of proinflammatory cyto-
kines in primary human chondrocyte cultures. In the present
study, we observed a similar level of binding between the BB0172
protein and the same !3"1 integrin, but in an RGD-independent
manner, since BB0172 lacks this motif. Integrin !3"1 binds to
collagen I and IV, laminin, fibronectin, and nidogen, and in some
cell types to thrombospondin 1 (73–76). Integrin !3"1 is also crit-
ical for the formation of kidneys and epidermis, and also inwound
healing, and it is significantly expressed by neurons in the brain
(73–76).
Interestingly, we found that BB0172 has a MIDAS sequence
motif at residues 57 to 61 (DXSXS), which is highly conserved
among Borrelia species. Mutations of these amino acid residues
reduced recombinant BB0172 binding to integrin !3"1, with the
strongest impact seen with the triple mutant (AXAXA), which
reduced the binding to near background levels. We hypothesized
that these mutations reduced the ability of BB0172 to coordinate
metals, thus diminishing capability of the protein to bind integrin
!3"1. Consequently, we speculate that the vWFA domain of
BB0172 includes a MIDAS domain similar to that found in the
I-domain of integrins (77–81), which is essential to maintain the
protein’s function. Further studies are in progress with the aim of
deleting bb0172 from B. burgdorferi and complementing it with its
native form and the mutated versions. We propose that this mu-
tation might reduce the ability of B. burgdorferi to bind to tissues
where integrin!3"1 is highly expressed, e.g., the basolateral mem-
brane in epidermis, glomerular podocytes in the kidney, and col-
lecting tubes and neurons in the brain (74).
In summary, the results of the present study prove that BB0172
is a surface-exposed membrane protein that displays a significant
capacity to bind integrin!3"1. Furthermore, the in vitro transcrip-
tion/translation strategy utilized here could be useful for further
studies of the helical membrane proteins of fastidiously growing
bacteria. The technique developed in this paper was demonstrated
to correlate well with studies of whole-protein localization on the
borrelial surface, validating the potential use of this technology
with other hypothetical membrane proteins of B. burgdorferi. Fi-
nally, this is the first report of ametal-dependent borrelial adhesin
with an active MIDAS motif that is essential for maintaining pro-
tein function.
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